Effect of latrunculin-B on outflow facility in monkeys

Exp Eye Res. 2000 Mar;70(3):307-13. doi: 10.1006/exer.1999.0797.

Abstract

Latrunculin-B (LAT-B), a macrolide derived from the marine sponge Latrunculia magnifica, sequesters monomeric G-actin, leading to the disassembly of actin filaments in cultured cells. In this study, we determined the effect of LAT-B on outflow facility in living monkeys. Total outflow facility was measured by 2-level constant pressure perfusion of the anterior chamber (AC) before and immediately after AC exchange infusion or 2 hr after topical application of LAT-B or vehicle. Both AC exchange infusion and topical application of LAT-B dose- and time-dependently increased outflow facility by two- to four-fold. Those findings suggest that pharmacological disorganization of the actin cytoskeleton in the trabecular meshwork by specific actin inhibitors such as LAT-B may be a useful anti-glaucoma strategy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Aqueous Humor / physiology
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology*
  • Dose-Response Relationship, Drug
  • Macaca fascicularis
  • Marine Toxins / pharmacology*
  • Thiazoles / pharmacology*
  • Thiazolidines
  • Trabecular Meshwork / drug effects*
  • Trabecular Meshwork / physiology

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Marine Toxins
  • Thiazoles
  • Thiazolidines
  • latrunculin B